{"id":96960,"date":"2009-12-23T18:49:38","date_gmt":"2009-12-23T23:49:38","guid":{"rendered":"http:\/\/www.stoth.com\/2009\/12\/23\/23andme-completes-27-8-million-series-b-round\/"},"modified":"2009-12-23T18:49:38","modified_gmt":"2009-12-23T23:49:38","slug":"23andme-completes-27-8-million-series-b-round","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/96960","title":{"rendered":"23AndMe Completes $27.8 Million Series B Round"},"content":{"rendered":"

<\/p>\n

\"\"Personal genomics startup 23andMe<\/a> has recently raised another $14.2 million to close out its $27.8 million Series B round, according to regulatory filings<\/a> with the SEC. The filing indicates that the new funding is an amendment to the company’s previously reported raise<\/a> of $11 million in May, which was followed by an additional $2.6 million<\/a> in June. We’ve reached out to 23andMe to confirm the funding amount, and to also determine if there are any new investors. Update:<\/b> 23andMe have confirmed that they’ve raised funding, but have not yet confirmed the amount.<\/p>\n

The last few months have been rocky for the company. In September, co-founder Linda Avey left<\/a> 23andMe to start a foundation dedicated to studying Alzheimer\u2019s disease. In late October, the company laid off<\/a> a substantial chunk of its workforce, but declined to comment on how many people were affected.<\/p>\n

23andMe is one of the first personal genomics companies, allowing customers to have portions of their DNA analyzed for around $400 (there are a few different products available). After completing a test, customers can log into the site to get reports on their genetic makeup, including a listing of some diseases they may be at risk for.<\/p>\n

\n
\n
CrunchBase Information<\/a><\/div>\n<\/div>\n
\n
23andMe<\/a><\/div>\n
<\/div>\n
Information provided by CrunchBase<\/a><\/div>\n<\/div>\n<\/div>\n

Crunch Network<\/em><\/strong>: MobileCrunch<\/a> <\/em>Mobile Gadgets and Applications, Delivered Daily.<\/p>\n

<\/img><\/a>
\n<\/img><\/a><\/p>\n

\n<\/img><\/a> <\/img><\/a> <\/img><\/a> <\/img><\/a> <\/img><\/a>\n<\/div>\n

<\/p>\n

Buy This Item: [Click here to buy this item]<\/span><\/a><\/p>\n

Read Original Article<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Personal genomics startup 23andMe has recently raised another $14.2 million to close out its $27.8 million Series B round, according to regulatory filings with the SEC. The filing indicates that the new funding is an amendment to the company’s previously reported raise of $11 million in May, which was followed by an additional $2.6 million […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-96960","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/96960","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=96960"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/96960\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=96960"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=96960"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=96960"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}